Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 11NIH 1NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 23Leukemia, Myeloid, Acute 9Congenital Abnormalities 7Leukemia, Megakaryoblastic, Acute 6Leukemia, Myelomonocytic, Acute 5Leukemia, Monocytic, Acute 5Leukemia, Erythroblastic, Acute 5Lymphoma 3Melanoma 2Leukemia, Promyelocytic, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2HIV Infections 2Unspecified Adult Solid Tumor, Protocol Specific 1Precancerous Conditions 1Papillomavirus Infections 1Neuroblastoma 1Myelodysplastic Syndromes 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphohistiocytosis, Hemophagocytic 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Kidney Neoplasms 1Hodgkin Disease 1Epstein-Barr Virus Infections 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

nilotinib 3bosutinib 2Imatinib Mesylate 2Filgrastim 2Dasatinib 2Cytogenetic Analysis 2ruxolitinib 1pembrolizumab 1liposomal amphotericin B 1asciminib 1Watchful Waiting 1Vancomycin 1Tyrosine Kinase Inhibitors 1Transplantation 1Tazobactam 1Specimen Handling 1Polymerase Chain Reaction 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Pharmaceutical Preparations 1Peripheral Blood Stem Cell Transplantation 1Moxifloxacin 1Morphine 1Microscopy 1Methylprednisolone Hemisuccinate 1Methylprednisolone Acetate 1Methylprednisolone 1Interferon-alpha 1In Situ Hybridization, Fluorescence 1Idarubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Leukemia, Myeloid, Chronic-Phase × Flow Cytometry × Clear all
NCT01395628 2016-05-19

Cell Samples From Patients With Leukemia

Children's Oncology Group

Completed
10 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Chronic-Phase, Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡